ST. JUDE MEDICAL ANNOUNCES FDA CLEARANCE OF ENSITE SYSTEM 6 SOFTWARE FOR CARDIAC MAPPING AND NAVIGATION

May 17, 2006

St. Jude Medical, Inc. announced May 15 U.S. Food and Drug Administration (FDA) clearance of the EnSite System Version 6 software, which provides improved clinical capabilities for cardiac mapping and navigation during electrophysiology (EP) procedures.
St. Jude Medical

KEYWORDS FDAnews Device Daily Bulletin

UK Study Says Single Shot of Pfizer/BioNTech Vaccine Significantly Lessened Asymptomatic Infections

ST. JUDE MEDICAL ANNOUNCES FDA CLEARANCE OF ENSITE SYSTEM 6 SOFTWARE FOR CARDIAC MAPPING AND NAVIGATION

Upcoming Events

FDA Drug GMP Facility Inspections During the Pandemic

Pharmaceutical Naming Regulation: Understanding the Latest Developments

Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

Biological Risk Evaluation and Management for Medical Devices

GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

UK Study Says Single Shot of Pfizer/BioNTech Vaccine Significantly Lessened Asymptomatic Infections

Eurofins Receives FDA Emergency Authorization for Over-the-Counter COVID-19 Test

Vetex Medical’s Thrombectomy Catheter Cleared by FDA

Merck Purchases Rights to Debiopharm’s Xevinapant for More Than $1 Billion

The Revised ICH E8: A Guide to New Clinical Trial Requirements